TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | — | $900.0M |
| Jun 2017 | — | — | $599.0M |
| Sep 2017 | — | — | $680.0M |
| Dec 2017 | $28.83B | $17.36B | $963.0M |
| Mar 2018 | — | $18.62B | $1.42B |
| Jun 2018 | — | $17.94B | $1.86B |
| Sep 2018 | — | $17.73B | $1.88B |
| Dec 2018 | — | $14.71B | $1.78B |
| Mar 2019 | — | $14.73B | $1.97B |
| Jun 2019 | — | $14.12B | $2.17B |
| Sep 2019 | — | $13.79B | $1.24B |
| Dec 2019 | — | $13.97B | $1.98B |
| Mar 2020 | — | $13.53B | $1.80B |
| Jun 2020 | — | $13.85B | $2.40B |
| Sep 2020 | — | $9.59B | $1.83B |
| Dec 2020 | — | $10.03B | $2.18B |
| Mar 2021 | — | $10.00B | $1.74B |
| Jun 2021 | — | $10.32B | $2.44B |
| Sep 2021 | — | $10.47B | $2.05B |
| Dec 2021 | — | $10.28B | $2.17B |
| Mar 2022 | — | $9.34B | $2.18B |
| Jun 2022 | — | $9.04B | $2.06B |
| Sep 2022 | — | $8.77B | $2.23B |
| Dec 2022 | — | $7.80B | $2.80B |
| Mar 2023 | — | $7.86B | $2.14B |
| Jun 2023 | — | $7.05B | $2.67B |
| Sep 2023 | — | $6.93B | $2.25B |
| Dec 2023 | — | $7.51B | $3.23B |
| Mar 2024 | — | $7.28B | $2.99B |
| Jun 2024 | — | $6.36B | $2.26B |
| Sep 2024 | — | $6.07B | $3.32B |
| Dec 2024 | — | $5.37B | $3.30B |
| Mar 2025 | — | $6.26B | $1.70B |
| Jun 2025 | — | $6.83B | $2.16B |
| Sep 2025 | — | $7.25B | $2.20B |
| Dec 2025 | — | $7.91B | $3.56B |
| Mar 2026 | — | $8.23B | $3.74B |
| Jun 2026 | — | $7.75B | $3.66B |